7.95
Schlusskurs vom Vortag:
$8.14
Offen:
$8.2
24-Stunden-Volumen:
13,794
Relative Volume:
0.02
Marktkapitalisierung:
$10.54M
Einnahmen:
$1.47M
Nettoeinkommen (Verlust:
$-97.61M
KGV:
-5.3356
EPS:
-1.49
Netto-Cashflow:
$-80.90M
1W Leistung:
+0.63%
1M Leistung:
-35.37%
6M Leistung:
-15.25%
1J Leistung:
-48.54%
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Firmenname
Lyra Therapeutics Inc
Sektor
Branche
Telefon
617-373-4600
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Vergleichen Sie LYRA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
LYRA
Lyra Therapeutics Inc
|
7.95 | 13.01M | 1.47M | -97.61M | -80.90M | -1.49 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-05-07 | Herabstufung | BofA Securities | Buy → Underperform |
2024-05-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-05-07 | Herabstufung | Jefferies | Buy → Hold |
2024-05-06 | Herabstufung | William Blair | Outperform → Mkt Perform |
2023-10-06 | Fortgesetzt | BTIG Research | Buy |
2023-08-31 | Eingeleitet | H.C. Wainwright | Buy |
2022-05-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-05-26 | Eingeleitet | BTIG Research | Buy |
2020-05-26 | Eingeleitet | BofA/Merrill | Buy |
2020-05-26 | Eingeleitet | Jefferies | Buy |
2020-05-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten
How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com
What makes Lyra Therapeutics Inc. stock price move sharplyHigh Return Potential - Newser
Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional
What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com
Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus
How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada
Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria
Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com
Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World
Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks
Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com
Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World
HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World
Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise
Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):